Histological Tumor Type is Associated with One-Year Cause-Specific Survival in Women with Stage III–IV Epithelial Ovarian Cancer: A Surveillance, Epidemiology, and End Results (SEER) Database Population Study, 2004

Histological Tumor Type is Associated with One-Year Cause-Specific Survival in Women with Stage III–IV Epithelial Ovarian Cancer: A Surveillance, Epidemiology, and End Results (SEER) Database Population Study, 2004–2014

Published:2020-01-20 Issue: Volume:26 Page:
ISSN:1643-3750
Container-title:Medical Science Monitor
language:en
Short-container-title:Med Sci Monit

Author:

Wu San-Gang¹,Li Feng-Yan²,Lei Jian³,Hua Li³,He Zhen-Yu³,Zhou Juan³

Affiliation:

1. Department of Radiation Oncology, Cancer Hospital, the First Affiliated Hospital of Xiamen University, Teaching Hospital of Fujian Medical University, Xiamen, Fujian, China (mainland)

2. Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, Guangdong, China (mainland)

3. Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xiamen University, Teaching Hospital of Fujian Medical University, Xiamen, Fujian, China (mainland)

Publisher

International Scientific Information, Inc.

Subject

General Medicine

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating age and ethnicity as novel high-risk phenotypes in mucinous ovarian cancer: retrospective study in a multi-ethnic population;International Journal of Gynecologic Cancer;2024-06-11

2. Real‐world study of lymphadenectomy in patients with advanced epithelial ovarian cancer;Journal of Obstetrics and Gynaecology Research;2024-02-08

3. Norepinephrine induces anoikis resistance in high-grade serous ovarian cancer precursor cells;JCI Insight;2024-01-25

4. Selective Inhibition of L-type Amino Acid Transporter 1 Suppresses Cell Proliferation in Ovarian Clear Cell Carcinoma;Anticancer Research;2023-05-29

5. Observation of the therapeutic effect of apatinib in advanced platinum-resistant recurrent epithelial ovarian cancer;Journal of Ovarian Research;2023-02-23